David Itamar 4
4 · Enox Biopharma Inc · Filed Aug 18, 2010
Insider Transaction Report
Form 4
David Itamar
Chief Financial Officer
Transactions
- Purchase
Common Stock
2010-08-12$2.00/sh+25,000$50,000→ 525,483 total - Purchase
Warrant
2010-08-12+12,500→ 12,500 totalExercise: $4.00From: 2010-08-12Exp: 2012-08-12→ Commom Stock (12,500 underlying) - Purchase
Common Stock
2010-07-15$0.30/sh+201,122$60,337→ 500,483 total
Footnotes (4)
- [F1]Reporting Person disclaims beneficial ownership of shares owned by his spouse, Hadas David.
- [F2]Purchase agreement includes a one year adjusting pre-emption provision to increase number of shares of holder upon payment of par value, at Reporting Person's election if Company sells shares at less than purchase price.
- [F3]Exercise price subject to downward formula adjustment if Company sells or commits to sell shares at less than $2.00 during the one year after issuance of Warrant.
- [F4]Exercise period subject to extension equal to expiration date of any different class of warrants sold by company during the one year after issuance of Warrant.